Abstract

The U.S. Food and Drug Administration (FDA) is revising 21 CFR Part 820 to directly incorporate ISO 13485:2016. This change reduces the effort required to comply with FDA and international regulations, ultimately broadening market access for medical device manufacturers. This article aims to ease the transition by breaking down the changes to 21 CFR 820, discussing the effect of the changes and identifying the correlating FDA and ISO regulations.